{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:35:11Z","timestamp":1782549311959,"version":"3.54.5"},"reference-count":28,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:p>\n            Objective\u2003Ampicillin is used for multiple peripartum indications including prevention of neonatal group B streptococcus (GBS) and treatment of chorioamnionitis. Despite its widespread use in obstetrics, existing pharmacokinetic data for ampicillin do not address contemporary indications or dosing paradigms for this population. We sought to characterize the pharmacokinetic profile of ampicillin administered to laboring women.<\/jats:p><jats:p>\n            Study Design\u2003Using whole blood dried blood spot sampling technique, maternal blood samples were collected at specified times from 31 women receiving intravenous (IV) ampicillin for peripartum indications. Women received either a 2-g loading dose with 1-g administered every 4\u2009hours (GBS) or 2-g every 6\u2009hours (chorioamnionitis). Pharmacokinetics were analyzed via a population approach with nonlinear mixed-effect modeling.<\/jats:p><jats:p>\n            Results\u2003The data were best described by a two-compartment model with first-order elimination, with the following whole blood parameters: central volume of distribution (V1), 75.2\u2009L (95% confidence interval [CI]: 56.3\u201393.6); clearance (CL), 82.4 L\/h (95% CI: 59.7\u201395.7); intercompartmental clearance (Q), 20.9 L\/h (95% CI: 16.2\u201338.2); and peripheral volume of distribution (V2), 61.1\u2009L (95% CI: 26.1\u2013310.5). Interpatient variation in CL and V1 was large (42.0 and 56.7%, respectively). Simulations of standard dosing strategies demonstrated over 98% of women are predicted to achieve an estimated free plasma concentration above mean inhibitory concentration (MIC) of 0.5 \u03bcg\/mL for more than 50% of the dosing interval.<\/jats:p><jats:p>\n            Conclusion\u2003Although large variation in the pharmacokinetics of ampicillin in pregnant women exists, as predicted by our model, current standard dosing strategies achieve adequate exposure for GBS in nearly all patients.<\/jats:p><jats:p>\n            Key Points\n          <\/jats:p>","DOI":"10.1055\/a-1674-6394","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T22:54:04Z","timestamp":1634770444000},"page":"127-133","source":"Crossref","is-referenced-by-count":3,"title":["Ampicillin Pharmacokinetics in Peripartum and Laboring Women"],"prefix":"10.1055","volume":"41","clinical-trial-number":[{"clinical-trial-number":"nct02427932","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Amy E.","family":"Judy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Frymoyer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Drover","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-4542","authenticated-orcid":false,"given":"Brendan","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-2005-873235","article-title":"Use of over-the-counter medications and herbal remedies in pregnancy","volume":"22","author":"J S Refuerzo","year":"2005","journal-title":"Am J Perinatol"},{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1067\/mob.2003.223","article-title":"Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population","volume":"188","author":"D D Glover","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"51.e1","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"205","author":"A A Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1213\/ANE.0000000000001143","article-title":"Pharmacokinetics and pharmacodynamics of drugs commonly used in pregnancy and parturition","volume":"122","author":"J Ansari","year":"2016","journal-title":"Anesth Analg"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/cc9091","article-title":"Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock","volume":"14","author":"F S Taccone","year":"2010","journal-title":"Crit Care"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0002-9378(93)90515-K","article-title":"Pharmacokinetics of ampicillin and sulbactam in pregnancy","volume":"168","author":"A Chamberlain","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/infdis\/136.3.370","article-title":"Pharmacokinetics of ampicillin during pregnancy","volume":"136","author":"A Philipson","year":"1977","journal-title":"J Infect Dis"},{"issue":"07","key":"ref8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0002-9378(66)90438-8","article-title":"Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancy","volume":"96","author":"R E Bray","year":"1966","journal-title":"Am J Obstet Gynecol"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01641464","article-title":"Transfer of ampicillin to the fetus and amniotic fluid during continuous infusion (steady state) and by repeated single intravenous injections to the mother","volume":"2","author":"H A Hirsch","year":"1974","journal-title":"Infection"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007691-198303000-00003","article-title":"Intravenous ampicillin pharmacokinetics in the third trimester of pregnancy","volume":"5","author":"R T Kubacka","year":"1983","journal-title":"Ther Drug Monit"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10928-009-9143-7","article-title":"Evaluation of different tests based on observations for external model evaluation of population analyses","volume":"37","author":"K Brendel","year":"2010","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","article-title":"Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R","volume":"90","author":"E Comets","year":"2008","journal-title":"Comput Methods Programs Biomed"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/FTD.0000000000000466","article-title":"Comparative analysis of ampicillin plasma and dried blood spot pharmacokinetics in neonates","volume":"40","author":"J Le","year":"2018","journal-title":"Ther Drug Monit"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1469-0691.2006.01617.x","article-title":"The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis","volume":"13","author":"D S Burgess","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"S 03","key":"ref15","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1086\/321854","article-title":"Does the dose matter?","volume":"33","author":"W A Craig","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref16","first-page":"279","article-title":"Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics","volume":"49","author":"P H Hinderling","year":"1997","journal-title":"Pharmacol Rev"},{"issue":"11","key":"ref17","first-page":"701","article-title":"Clinical studies on the effect of pregnancy and labor on the pharmacokinetics of ampicillin [in German]","volume":"100","author":"R Voigt","year":"1978","journal-title":"Zentralbl Gyn\u00e4kol"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2005.07.098","article-title":"Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of Group B Streptococcus","volume":"194","author":"D F Colombo","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000457744","article-title":"Clinical pharmacokinetics in pregnancy and perinatology. II. Penicillins","volume":"10","author":"H Nau","year":"1987","journal-title":"Dev Pharmacol Ther"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5414\/CPP44057","article-title":"Placental transfer of antibiotics administered to the mother: a review","volume":"44","author":"G M Pacifici","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jps.2600620112","article-title":"Comparison of ampicillin and hetacillin pharmacokinetics in man","volume":"62","author":"W J Jusko","year":"1973","journal-title":"J Pharm Sci"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1124\/dmd.112.050245","article-title":"Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?","volume":"41","author":"N Isoherranen","year":"2013","journal-title":"Drug Metab Dispos"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-3476(76)80446-5","article-title":"Antibiotic-killing kinetics of group B streptococci","volume":"89","author":"V Schauf","year":"1976","journal-title":"J Pediatr"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/infdis\/157.1.113","article-title":"Intraamniotic infection in low-birth-weight infants","volume":"157","author":"R S Sperling","year":"1988","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0002-9378(91)90707-X","article-title":"Progress in pathogenesis and management of clinical intraamniotic infection","volume":"164","author":"R S Gibbs","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"01","key":"ref28","first-page":"1","article-title":"Prevention of group B streptococcal early-onset disease in newborns. ACOG committee opinion, number 782","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamapediatrics.2016.4678","article-title":"A quantitative, risk-based approach to the management of neonatal early-onset sepsis","volume":"171","author":"M W Kuzniewicz","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"e20191881","DOI":"10.1542\/peds.2019-1881","article-title":"Management of infants at risk for group B streptococcal disease","volume":"144","author":"K M Puopolo","year":"2019","journal-title":"Pediatrics"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1674-6394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:14:11Z","timestamp":1730801651000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1674-6394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":28,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,1,16]]},"published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1674-6394","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"value":"0735-1631","type":"print"},{"value":"1098-8785","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,20]]},"published":{"date-parts":[[2021,10,20]]}}}